ARTICLE | Company News
Optimata, Novartis deal
January 14, 2002 8:00 AM UTC
Optimata will use its mathematical algorithms and software tools with clinical and preclinical data to assess the mechanism of action of a compound under development by NOVN's Novartis Pharmaceutical ...